Results 71 to 80 of about 5,338,541 (183)
, 2021 PurposeTo investigate the comparative efficacy of intense pulsed light (IPL) therapy alone with that of IPL plus meibomian gland expression (MGX) for meibomian gland dysfunction (MGD).MethodsThis is a prospective randomized crossover clinical trial ...
Chan Hee Moon +4 more
core +1 more source
, 2020 Purpose: The aim of this study was to use swept-source anterior segment optical coherence tomography (OCT) to explore imaging the meibomian gland openings and to identify their in vivo characteristics in patients with obstructive meibomian gland ...
Xinhan Cui +6 more
core +1 more source
Meibomian gland scores of the upper and lower eyelid.
, 2023 Grade 0: No loss of Meibomian glands; Grade 1: Loss of Meibomian glands less than one third of the total density on the eyelid; Grade 2: Loss between one and two thirds of the total density of the glands on the eyelid; Grade 3: Loss of glands is greater ...
Amr Saad (5955308) +3 more
core +1 more source
Journal of Ophthalmology, Volume 2026, Issue 1, 2026.Purpose To compare clinical and corneal epithelial changes between preservative and preservative‐free artificial tear therapy using the MS‐39 in patients with dry eye disease (DED). Methods This prospective interventional comparative study included 88 eyes of 44 patients. Preserved artificial tears were given for the left eye (group A) and preservative‐
Ghada A. Nassar +5 more
wiley +1 more source
Ophthalmology and TherapyIntroduction To assess the efficacy and safety of the combination of microblepharoexfoliation (MBE), intense pulse light (IPL) and meibomian gland expression (MGX) for treatment of meibomian gland dysfunction (MGD).
Antonio Ballesteros-Sánchez +3 more
doaj +1 more source
Clinical Ophthalmology, 2021 Natalia Mussi, Waqas Haque, Danielle M Robertson Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX, USACorrespondence: Danielle M RobertsonDepartment of Ophthalmology, The University of Texas Southwestern ...
Mussi N, Haque W, Robertson DM
doaj
Journal of Ophthalmology, Volume 2026, Issue 1, 2026.Objective To investigate the specific therapeutic effect of lifitegrast on symptoms and signs of dry eye disease (DED) patients, as well as to examine its treatment‐emergent adverse effects (TEAEs). Methods We conducted a systematic literature search in PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases from ...
Jiang Xiaodan +5 more
wiley +1 more source
Meibomian Gland Dysfunction – Update on Diagnosis and Management
Delhi Journal of OphthalmologyMeibomian gland dysfunction (MGD) is a leading cause of dry eye disease, characterized by abnormal meibum production and glandular obstruction, resulting in compromised tear film stability and ocular discomfort.
Apoorva Goyal +3 more
doaj +1 more source
Drug‐Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper
Allergy, Volume 80, Issue 11, Page 2953-2972, November 2025.ABSTRACT Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life‐threatening complications. Drug‐induced ocular adverse reactions are generally classified into two primary categories: toxic reactions ...
Andrea Leonardi +16 more
wiley +1 more source
, 2023 To evaluate the efficacy and safety of intense pulsed light combined with meibomian gland expression (IPL-MGX) for treating meibomian gland dysfunction (MGD) associated with chronic ocular graft-versus-host disease (oGVHD).
Xi Song (4538008) +4 more
core +1 more source